GlucoTrack, Inc. , a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
Glucotrack stock last closed at $0.33, up 1.21% from the previous day, and has decreased 22.33% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.2 percentage points. Glucotrack stock is currently +151.13% from its 52-week low of $0.13, and -91.09% from its 52-week high of $3.75.
There are currently 20.89M GCTK shares outstanding. The market value of GCTK is $6.98M. In the last 24 hours, 158,603 GCTK shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy GCTK stock.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal details so you can invest in GCTK today.
Now that you've opened your account on apps for stocks, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring money into your new brokerage account.
Once you have figured out the best place to buy Glucotrack stock, it's crucial to analyze their stock prior to buying, so you can understand the risk and opportunity.
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on GCTK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge GCTK's fair value.
Using relative valuations metrics:
You can do more valuation research on GCTK's stock here.
Last year, GCTK revenue was $0.00. Over the last 5 year, GCTK's revenue has gone up by -100% per year. This was slower than the Medical Instruments & Supplies industry average of 9.68%.
You can analyze GCTK's earnings and revenue performance here.
In the last year, insiders at GCTK have not bought or sold any shares.
Learn more about who owns GCTK shares here.
No, Glucotrack doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two main order types:
Hit the Open button and your broker will execute your order.
If you need more help with buying stocks on eToro, watch the how to video below:
Now that you own some GCTK shares, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to get the latest updates about your GCTK stock.
To reiterate, here are the 6 steps you need to take to buy Glucotrack stock right now:
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Glucotrack, get started below.